These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Blood glucose lowering sulfonamides with asymmetric carbon atoms. 3. Related N-substituted carbamoylbenzoic acids. Rufer C; Losert W J Med Chem; 1979 Jun; 22(6):750-2. PubMed ID: 458827 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and antihyperglycemic evaluation of new 2-hydrazolyl-4-thiazolidinone-5-carboxylic acids having pyrazolyl pharmacophores. Bhosle MR; Mali JR; Pal S; Srivastava AK; Mane RA Bioorg Med Chem Lett; 2014 Jun; 24(12):2651-4. PubMed ID: 24813740 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of 3,8,9-trisubstituted-1,7,9-triaza-fluorene-6-carboxylic acid derivatives as a new class of insulin secretagogues. Bahekar RH; Jain MR; Jadav PA; Goel A; Patel DN; Prajapati VM; Gupta AA; Modi H; Patel PR Bioorg Med Chem; 2007 Sep; 15(17):5950-64. PubMed ID: 17583514 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationship of 4-substituted benzoic acids and their inhibitory effect on the biosynthesis of fatty acids and sterols. Ohno T; Ogawa K; Yano S; Fukushima M; Suzuki N; Asao T Arch Pharm (Weinheim); 2005 Apr; 338(4):147-58. PubMed ID: 15818566 [TBL] [Abstract][Full Text] [Related]
10. [Hypoglycemic action of certain heterocyclic carboxylic acid derivatives]. Takasaki K; Kaneko M; Fujii T; Kobayashi H Nihon Yakurigaku Zasshi; 1973 Nov; 69(6):977-94. PubMed ID: 4799525 [No Abstract] [Full Text] [Related]
11. [Effect of oral hypoglycemic agents on gastric secretion (author's transl)]. Sakai K; Nakatani M; Yamasaki M Yakugaku Zasshi; 1981 Apr; 101(4):354-9. PubMed ID: 7288579 [No Abstract] [Full Text] [Related]
12. Synthesis and Characterization of Urofuranoic Acids: In Vivo Metabolism of 2-(2-Carboxyethyl)-4-methyl-5-propylfuran-3-carboxylic Acid (CMPF) and Effects on in Vitro Insulin Secretion. Nagy E; Liu Y; Prentice KJ; Sloop KW; Sanders PE; Batchuluun B; Hammond CD; Wheeler MB; Durham TB J Med Chem; 2017 Mar; 60(5):1860-1875. PubMed ID: 28171722 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological studies on the hypoglycemic effect of 7,8-dihydro-2-(4-methylpiperazinyl)-4-(1-pyrrolidinyl)-6H-thi opyrano [3,2-d] pyrimidine dimaleate (MTP-1307), a novel hypoglycemic agent. Kunoh Y; Ogawa H; Nagasaka M; Asai H; Iguchi A; Niki A; Sakamoto N Arch Int Pharmacodyn Ther; 1989; 298():276-87. PubMed ID: 2667487 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of some novel isochroman carboxylic acid derivatives as potential anti-diabetic agents. Lakshminarayana N; Rajendra Prasad Y; Gharat L; Thomas A; Ravikumar P; Narayanan S; Srinivasan CV; Gopalan B Eur J Med Chem; 2009 Aug; 44(8):3147-57. PubMed ID: 19349096 [TBL] [Abstract][Full Text] [Related]
15. 4-(trans-4-Methylcyclohexyl)-4-oxobutyric acid (JTT-608). A new class of antidiabetic agent. Shinkai H; Ozeki H; Motomura T; Ohta T; Furukawa N; Uchida I J Med Chem; 1998 Dec; 41(27):5420-8. PubMed ID: 9876112 [TBL] [Abstract][Full Text] [Related]
16. Discovery of a highly orally bioavailable c-5-[6-(4-Methanesulfonyloxyphenyl)hexyl]-2-methyl-1,3-dioxane-r-2-carboxylic acid as a potent hypoglycemic and hypolipidemic agent. Pingali H; Jain M; Shah S; Basu S; Makadia P; Goswami A; Zaware P; Patil P; Godha A; Giri S; Goel A; Patel M; Patel H; Patel P Bioorg Med Chem Lett; 2008 Oct; 18(20):5586-90. PubMed ID: 18805005 [TBL] [Abstract][Full Text] [Related]
17. Hypoglycaemic and insulinotropic effects of a novel oral antidiabetic agent, (-)-N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine (A-4166). Ikenoue T; Akiyoshi M; Fujitani S; Okazaki K; Kondo N; Maki T Br J Pharmacol; 1997 Jan; 120(1):137-45. PubMed ID: 9117089 [TBL] [Abstract][Full Text] [Related]
19. [Disinfectants based on peracid-splitting compounds (author's transl)]. Eggensperger H Zentralbl Bakteriol B; 1979 Jun; 168(5-6):517-24. PubMed ID: 506562 [TBL] [Abstract][Full Text] [Related]
20. Sulfonyliminoimidazolidines, a new class of oral hypoglycemic agents. 3. Hypoglycemic activity and mode of action of 1-[p-[2-(crotonylamino)-ethyl]-phenylsulfonyl]-3-cyclohexyl-2-imino- imidazolidine (CGP 11 112). Märki F; Albrecht W; de Gasparo M Arzneimittelforschung; 1983; 33(10):1455-63. PubMed ID: 6360181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]